Back

CHRT

-1.76%
GOOD

Cohort's MASS subsidiary wins £17.5m extension to JCAST training contract

Why we think this is good

The RNS announcement is positive overall, as it demonstrates the continued success of Cohort's MASS subsidiary in securing a significant contract extension with UK Strategic Command. MASS's position as a trusted supplier and the high-quality services it provides are highlighted, which is a positive indicator for the subsidiary's future growth prospects. However, the lack of financial details in the RNS makes it difficult to fully assess the impact on Cohort's overall performance and valuation.

Key Points

  • MASS Consultants Ltd, a Cohort subsidiary, has won a 2-year extension to the £17.5m+ Joint Command and Staff Training (JCAST) contract for UK Strategic Command
  • The contract extension highlights MASS's position as a trusted supplier and the high-quality services it provides
  • Shore Capital has maintained a "Buy" recommendation on Cohort's shares with a price target of 844p

Summary

The defense technology group's MASS subsidiary has won a £17.5m extension to its Joint Command and Staff Training contract with UK Strategic Command, highlighting its capabilities as a trusted supplier.

Cohort plc (AIM: CHRT), the independent technology group, has announced that its wholly owned subsidiary MASS Consultants Ltd has been awarded a 2-year extension to the Joint Command and Staff Training (JCAST) contract for UK Strategic Command, valued at over £17.5m. This contract extension demonstrates MASS's position as a trusted supplier and the high-quality services they continue to provide. The broker targets show that Shore Capital has maintained a "Buy" recommendation on Cohort's shares, with a price target of 844p.

Key Dates

July 2027
General
JCAST contract extension expires
Impact Score: 6
CONTRACT WIN